Juli / August 2005:

7.7.

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone
(VAD) as primary therapy in preparation for autologous
transplantation for multiple myeloma
Michele Cavo et al. for the writing committee of the Bologna 2002 study
BLOOD 106: 35-39, 2005

Comment on Cavo et al, page 35
Multiple myeloma:
the death of VAD as initial therapy
Blood, 1 JULY 2005 I VOLUME 106, NUMBER 1

Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Paul G. Richardson et al. for the Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators
N. Engl. J. Med 352:2487-2498, 2005

Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients
With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des
Lymphomes de l'Adulte
P. Feugier et al.
J Clin Oncol 2005;23 4117-4126

14.7.

Colony-Stimulating Factors for Chemotherapy-Induced Febrile Neutropenia: A
Meta-Analysis of Randomized Controlled Trials
Otavio A.C. Clark et al.
J Clin Oncol 2005;23 4198-4214

Treatment of Small Cell Lung Cancer in the Elderly
Antonio Ross et al.
The Oncologist 2005;10:399-411

21.7.

Catheter-Associated Thrombosis: Thromboprophylaxis or Not?
M. Levine and A.K. Kakkar
J Clin Oncol 2005;23 4006-4008

Enoxaparin for the Prevention of Venous Thromboembolism Associated With
Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study
in Cancer Patients
Melina Verso et al.
J Clin Oncol 2005;23 4057-4062

Randomized Placebo-Controlled Study of Low-Dose Warfarin for the Prevention
of Central Venous Catheter-Associated Thrombosis in Patients With Cancer
Stephen Couban et al.
J Clin Oncol 2005;23 4063-4069

28.7.

noch festzulegen

4./ 11./ 18. 8.

Sommerpause

25.8.

noch festzulegen

Mai / Juni 2005:

12.-17. 5.

ASCO-Jahreskongreß Orlando, FL

19.5.

Post-ASCO:

Mammakarzinome ( u.a. Herceptin adjuvant - HERA und US-Studien / Chemotherapiekombinationen adjuvant)

Bronchialkarzinome (Tyrosinkinaseinhibitoren)

2.6.

Post-ASCO:

Mammakarzinome (antihormonelle Therapie / Aromataseinhibitoren)

Kolorektalkarzinome (Bevacizumab/Avastin-ECOG 3200)

Pankreaskarzinome (Kombinationstherapien / EGFR-Antagonisten / adjuvante Therapie)

9.6.

Post-ASCO:

Kleinzellige Bronchialkarzinome (Chemotherapieoptionen)

Gastrointestinale Tumoren (adjuvante, perioperative Chemotherapie des Magenkarzinoms/Chemotherapieregime bei Metastasierung)

16.6.

Post-ASCO:

GIST (neue Daten / Substanzen)

Urogenitaltumoren

Nierenzellkarzinome (Tyrosinkinaseinhibitoren)

23.6.

Bericht vom Lymphom-Meeting, Lugano (Juni 2005)

POEMS syndrome: definitions and long-term outcome.
Dispenzieri A et al.
Blood. 2003 Apr 1;101(7):2496-506

Infektionen und Sepsis durch intravenöse Katheter
Widmer AF
Internist 46: 643-651 , 2005

Divertikulose und Divertikilitis
Hoffmann RM und Kruis W.
Internist 46: 671-684 , 2005

30.6.

Changing the Way We Think About Chronic Lymphocytic Leukemia
Thomas S. Lin et al.
J Clin Oncol 2005;23 4009-4012

Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia
William Wierda et al.
J Clin Oncol 2005;23 4070-4078 wil

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
Michael J. Keating et al.
J Clin Oncol 2005;23 4079-4088 art

März/April 2005:

3.3

EGFR Mutations in Non-Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment
Marchetti et al., J Clin Oncol 23: 857-865, 2005
(Nachtrag vom Februar)

10.3.

Systemic Therapy for Colorectal Cancer
Jeffrey A. Meyerhardt and Robert J. Mayer
N Engl. J Med 352: 476-487, 2005

Androgen Suppression Plus Radiation Versus Radiation Alone for Patients With Stage D1/Pathologic Node-Positive Adenocarcinoma of the Prostate: Updated Results Based on National Prospective Randomized Trial Radiation Therapy Oncology Group 85-31
Lawton et al., JCO Feb 1 2005: 800-807
(Nachträge vom Februar)

17.3.

Neue Parameter zur Diagnostik von Eisenmangelzuständen
Thomas et al. , Deutsches Ärzteblatt?Jg. 102?Heft 9?4. März 2005

Anemia of Chronic Disease
Weiss, G. and Goodnough LT; N Engl. J. Med 352:987-996, 2005

24.3 und 31.3 : Osterpause

7.4.

Adjuvant Endocrine Therapy for Premenopausal Women With Early Breast Cancer
Dellapasqua et al. ; JCO 10: 1736-1750, 2005

Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy
Arriagada et al; Ann Oncol 16(3):389-396, 2005

14.4.

Platinum-Based Versus Non-Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of the Published Literature
Giannicola D'Addario , JCO Early Release, published online ahead of print Feb 22 2005

21.4.

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer Patients Treated With Gefitinib
Sae-Won Han et al. ; JCO Early Release, published online ahead of print Feb 14 2005

Clinically Meaningful Improvement in Symptoms and Quality of Life for Patients With Non-Small-Cell Lung Cancer Receiving Gefitinib in a Randomized Controlled Trial
Cella et al; JCO Early Release, published online ahead of print Feb 7 2005

28.4.

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp R et al., , N Engl J Med 352:987-996, 2005

Februar 2005:

3.2

Renal cell carcinoma: review of novel single-agent therapeutics and combination regimens
Amato et al. ; Annals of Oncology 2005 16(1):7-15

10.2

Bericht vom POST-ASH Seminar, Köln, Januar 2005 (OA Artmann)

Meta-Analysis to Evaluate the Role of Interferon in Follicular Lymphoma
Rohatiner et al ; J Clin Oncol published January 31, 2005

Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)
Lenz et al., J Clin Oncol published January 31, 2005

Optimizing Rituximab in B-Cell Lymphoma (Editorial)
Sandra J. Horning ; J Clin Oncol published January 31, 2005

17.2

Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
Davide Mauri, Nicholas Pavlidis, and John P. A. Ioannidis; J Natl Cancer Inst 2005 97: 188-194.

Sometimes a Great Notion--An Assessment of Neoadjuvant Systemic Therapy for Breast Cancer
Davidson and Morrow, J Natl Cancer Inst 97: 159-160, 2005 (Editorial)

EGFR Mutations in Non-Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment
Marchetti et al., J Clin Oncol 23: 857-865, 2005

24.2

Systemic Therapy for Colorectal Cancer
Jeffrey A. Meyerhardt and Robert J. Mayer
N Engl. J Med 352: 476-487, 2005

Androgen Suppression Plus Radiation Versus Radiation Alone for Patients With Stage D1/Pathologic Node-Positive Adenocarcinoma of the Prostate: Updated Results Based on National Prospective Randomized Trial Radiation Therapy Oncology Group 85-31
Lawton et al., JCO Feb 1 2005: 800-807

Januar 2005:

13.1.

Neue ASCO-Leitlinien zur adjuvanten Therapie des Mammakarzinoms mit Aromataseinhibitoren
Winer et al.
J Clin Oncol 23: (Jan 20), 2005

20.1.

Systematic Review Evaluating the Timing of Thoracic Radiation Therapy in Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer
Fried et al,
J Clin Oncol 22:4837-4845, 2004

Palliative chemotherapy for advanced gastric cancer
Wöhrer et al..
Annals of Oncology 2004 15(11):1585-1595
27.1.

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis
Fiorica et al.
Gut 53:925-930, 2004